NCT02636608View on ClinicalTrials.gov

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

CompletedOBSERVATIONAL

Enrollment

244

Participants

Timeline

Start Date

November 27, 2015

Primary Completion Date

May 23, 2018

Study Completion Date

May 23, 2018

Conditions

Chronic Hepatitis C

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

IST GmbH, Germany

INDUSTRY

lead

AbbVie

INDUSTRY